Entero Healthcare Solutions Chart
Entero Healthcare Solutions Share Key Metrics
Volume
85746.00
Market Cap
5507.18 CR
LTQ@LTP
11@1265.70
ATP
1251.74
Var Margin
18.6 %
Circuit Range
968.7-1452.9
Delivery %
50.53 %
Value
10.73 CR
ASM/GSM
No
Market Lot
1
Summary
Entero Healthcare Solutions Fundamentals
View MoreP/E Ratio
46.56
P/B Ratio
2.92
Div. Yield
0
Sector P/E
43.34
Sector P/B
2.14
Sec. Div. Yield
80.27
Entero Healthcare Solutions Resistance and Support
Pivot 1205.6
Resistance
First Resistance
1226.2
Second Resistance
1241.6
Third Resistance
1262.2
Support
First Support
1190.2
Second Support
1169.6
Third Support
1154.2
Entero Healthcare Solutions Corporate Actions
| Date | Agenda |
|---|---|
| 2026-02-12 | Quarterly Results |
Entero Healthcare Solutions News
Entero Healthcare Solutions Limited
Entero Healthcare Solutions Limited's subsidiary, Rada Medisolutions Private Limited, has received approval for the amalgamation of its two wholly-owned subsidiaries, Chethana Pharma Distributors Private Limited and CPD Pharma Private Limited. This internal restructuring aims to simplify the group structure and enhance operational efficiencies.
May 06 2026 19:05:00
Entero Healthcare Solutions Ltd - 544122 - Announcement under Regulation 30 (LODR)-Scheme of Arrangement
Entero Healthcare Solutions announced that the Ministry of Corporate Affairs has approved the scheme of amalgamation for its group entities. Chethana Pharma Distributors Private Limited and CPD Pharma Private Limited will merge into Rada Medisolutions Private Limited, aiming for operational efficiencies and group structure simplification. The scheme is effective from April 15, 2025.
May 06 2026 19:05:00
About Entero Healthcare Solutions AboutThe
NSE : 22717
BSE : 544122
ISIN : INE010601016
Our Company was incorporated as ‘Entero Healthcare Solutions Private Limited’ as a private limited company under the Companies Act 2013 pursuant to a certificate of incorporation dated January 10 2018 issued by the Registrar of Companies Central Registration Centre under the administrative control of the Registrar of Companies Delhi and Haryana at New Delhi. Subsequently our Company was converted into a public limited company pursuant to a special resolution passed in the annual general meeting of our Shareholders held on August 7 2023 and consequently the name of our Company was changed to ‘Entero Healthcare Solutions Limited’ and a fresh certificate of incorporation dated August 25 2023 was issued by the RoC.Major events and milestones:2018-Our Company was incorporated in January 2018.2018-Received investment from OrbiMed Asia III Mauritius Limited and IM Investments Trust.-Acquired Novacare Healthcare Solutions Private Limited which was our first acquisition.2019-Crossed monthly turnover of ? 1000 million.2020-Achieved positive EBITDA in our second year of being operational.-Entered into our first promotion marketing and distribution partnership with Roche Products (India) Private Limited.2022-Acquired SS Pharma Traders Private Limited which was our 32nd acquisition.
Entero Healthcare Solutions Management
| Name | Position |
|---|---|
| Sanu Kapoor | Vice president- General Counsel, Company Secretary & Compliance Officer |
| Sujesh Vasudevan | Chairman |
Entero Healthcare Solutions Similar Stocks
Ion Exchange (India) Ltd.
426.50
10.10 (2.43%)
Latent View Analytics Ltd.
310.60
6.70 (2.20%)
Elitecon International Ltd.
36.36
-0.12 (0.33%)
SIS Ltd.
398.15
6.65 (1.70%)
Symphony Ltd.
808.90
-9.75 (1.19%)
Smartworks Coworking Spaces Ltd.
461.50
0.20 (0.04%)
GNG Electronics Ltd.
441.70
7.80 (1.80%)
CMS Info Systems Ltd.
287.80
-3.35 (1.15%)
Sun Pharma Advanced Research Company Ltd.
166.85
9.77 (6.22%)
Zota Health Care Ltd.
1304.80
-11.60 (0.88%)
Entero Healthcare Solutions FAQs
